))
Radioisotopes are revolutionizing how cancers are detected and treated. But how do they work? And where is this field headed? Whether you’re a healthcare professional, researcher, pharma exec, or industry analyst, this podcast is a go-to resource for the rapidly evolving radiopharmaceuticals landscape. Welcome to Talk Radioisotopes: Going Nuclear on Cancer. We’ll take a look at the latest insights, trends and developments working to change patient outcomes and supply the fight against cancer ...
…
continue reading
1
Building a Smarter Radiopharma Future with AI-Driven Drug Discovery
21:22
21:22
Play later
Play later
Lists
Like
Liked
21:22
In this episode of Talk Radioisotopes, host Scott Ravi sits down with Sigal Kalmanson Cusnir, CEO and Co-Founder of Starget Pharma, an early-stage company at the forefront of precision oncology. Starget is redefining the way radiopharmaceuticals are discovered and developed by merging AI technology with decades of expertise in peptide chemistry. Si…
…
continue reading
1
The Goldilocks Isotope? Why Astatine-211 Might Be Just Right for Radiotherapeutics
36:22
36:22
Play later
Play later
Lists
Like
Liked
36:22
In this episode, Milton Lönnroth, Co-Founder and CEO, shares how Atley Solutions is changing the game for astatine-211, a promising isotope in cancer therapy. Atley supports radiopharmaceutical companies and researchers by enabling the scalable production and labeling of astatine-based compounds. Milton explains how the company's roots in the Unive…
…
continue reading
In this episode, host Scott Larrivee speaks with Dr. Luke Nordquist, a medical oncologist and Founder/CEO of XCancer, a globally recognized clinical research center. Dr. Nordquist shares the origin story of XCancer—born out of a desire to bring cutting-edge prostate cancer trials to community care settings—and how it has grown into a nationwide cli…
…
continue reading
On this episode, hosts Scott and Sarah are joined by Matt Furlow, Associate Principal at ZS, about the evolving role of radiopharmaceuticals in oncology. With a PhD in bioengineering and a decade of consulting experience, Matt brings a unique perspective on how scientific insight and strategic planning intersect to help biotech and pharma companies…
…
continue reading
1
Suzanne Lapi, Professor of Radiology and Chemistry and Cyclotron Facility Director at the University of Alabama at Birmingham
31:14
31:14
Play later
Play later
Lists
Like
Liked
31:14
On this episode, hosts Scott and Sarah sit down with Dr. Suzanne Lapi, Professor of Radiology and Chemistry and Cyclotron Facility Director at the University of Alabama at Birmingham. The conversation dives into Dr. Lapi’s multifaceted role in radiopharmaceutical research, isotope production, and academic training. She shares how her team at UAB de…
…
continue reading
1
Shamar Young, Chief Medical Officer at TeleDaaS
31:38
31:38
Play later
Play later
Lists
Like
Liked
31:38
On this episode of Talk Radioisotopes, Scott and Sarah are joined by Dr. Shamar Young, Chief Medical Officer at TeleDaaS and Division Chief of Interventional Radiology at the University of Arizona. The discussion explores Dr. Young’s journey into interventional radiology, his expertise in Yttrium-90 (Y90) therapy, and the evolving role of precision…
…
continue reading
1
Bruno Paquin, CEO of AtomVie Global Radiopharma
40:57
40:57
Play later
Play later
Lists
Like
Liked
40:57
In this episode of Talk Radioisotopes, hosts Scott and Sarah welcome Bruno Paquin, CEO of AtomVie Global Radiopharma. Bruno delves into the complexities and advancements of the radiopharmaceutical industry. The discussion highlights AtomVie’s role as a leading contract development and manufacturing organization (CDMO), their cutting-edge work in ca…
…
continue reading
On this episode of Talk Radioisotopes, hosts Scott Larrivee and Sarah Scouten interview Arjun Murthy, co-founder of Maven Bio, an AI-driven biopharma market intelligence platform. They explore how Arjun's background, along with Maven Bio's technology, is transforming data analysis and research in the biopharma sector. Key topics include how AI is a…
…
continue reading
1
Shaemus Gleason, Executive Vice President, Clarity Pharmaceuticals
45:17
45:17
Play later
Play later
Lists
Like
Liked
45:17
On this episode, hosts Scott and Sarah sit down with Shaemus Gleason, Executive Vice President at Clarity Pharmaceuticals. The discussion highlights Shaemus's journey through the radiopharmaceutical industry, Clarity's innovations, and breakthroughs involving copper-based compounds for cancer treatment. Shaemus shares insights on the importance of …
…
continue reading
1
Jeff Jones, Managing Director, Senior Analyst at Oppenheimer & Company
36:37
36:37
Play later
Play later
Lists
Like
Liked
36:37
On our first episode of ‘Talk Radioisotopes: Going Nuclear on Cancer,' host Scott Larrivee is joined by co-host Dr. Sarah Scouten and guest Jeff Jones of Oppenheimer & Company. The discussion covers the latest trends in the radiopharmaceutical and radiotherapeutics markets, including the rise of targeted radiotherapies, the involvement of large pha…
…
continue reading
1
Trailer - Talk Radioisotopes: Going Nuclear on Cancer
1:16
1:16
Play later
Play later
Lists
Like
Liked
1:16
Radioisotopes are revolutionizing how cancers are detected and treated. But how do they work? And where is this field headed? Whether you’re a healthcare professional, researcher, pharma exec, or industry analyst, this podcast is a go-to resource for the rapidly evolving radiopharmaceuticals landscape. Welcome to Talk Radioisotopes: Going Nuclear o…
…
continue reading
